Abstract:Introduction: Drug interactions could account for 1% of hospitalizations in the general population and 2–5% of hospital admissions in the elderly. However, few data are available on the drugs concerned and the potential severity of the interactions encountered. We thus first aimed to estimate the prevalence of dispensings including drugs Contraindicated or Discommended because of Interactions (CDI codispensings) and to identify the most frequently involved drug pairs. Second, we aimed to investigate whether the frequency of CDI codispensings appeared higher or lower than the expected for the drugs involved.Methods: We carried out a study using a random sample of all drugs dispensings registered in a database of the French Health Insurance System between 2010 and 2015. The distribution of the drugs involved was described considering active principles, detailing the 20 most frequent ones for both contraindicated or discommended codispensings (DCs). To investigate whether the frequency of CDI codispensings appeared higher or lower than the expected for the drugs involved, we developed a specific indicator, the Drug-drug interaction prevalence study-score (DIPS-score), that compares for each drug pair the observed frequency of codispensing to its expected probability. The latter is determined considering the frequencies of dispensings of the individual drugs constituting a pair of interest.Results: We analyzed 6,908,910 dispensings: 13,196 (0.2%) involved contraindicated codispensings (CCs), and 95,410 (1.4%) DCs. For CCS, the most frequently involved drug pair was "bisoprolol+flecainide" (n = 5,036); four out of five of the most represented pairs involved cardiovascular drugs. For DCS, the most frequently involved drug pair was "ramipril+spironolactone" (n = 4,741); all of the five most represented pairs involved cardiovascular drugs. The drug pair involved in the CC with the highest score value was "citalopram+hydroxyzine" (DIPS-score: 3.7; 2.9–4.6); that with the lowest score was "clarithromycin+simvastatin" (DIPS-score: 0.2; 0.2–0.3). DIPS-score median value was 0.4 for CCs and 0.6 for DCs.Conclusion: This high prevalence of CDI codispensings enforces the need for further risk-prevention actions regarding drug-drug interactions (DDIs), especially for arrhythmogenic or anti-arrhythmic drugs. In this perspective, the DIPS-score we develop could ease identifying the interactions that are poorly considered by clinicians/pharmacists and targeting interventions.

Cross-sectional Survey and Clinical Significance of Potential Drug-drug In-teractions in Intensive Care Units

Assessment of frequency and types of drug interactions in intensive care units: a cross-sectional study

Implementation of Pharmacists' Interventions and Assessment of Medication Errors in an Intensive Care Unit of A Chinese Tertiary Hospital

Potential Therapeutic Hazards Due to Drug–drug Interaction Between Topically and Systemically Coadministered Medications

Prevalence of Potential Drug-Drug Interactions among Intensive Care Unit Patients Receiving Linezolid: a Cross-Sectional Study.

Effectiveness of Pharmaceutical Care in an Intensive Care Unit from China A Pre- and Post-Intervention Study

Clinically Significant Cytochrome P450-Mediated Drug-Drug Interactions in Children Admitted to Intensive Care Units

Evaluation of Potentially Inappropriate Prescription and Drug-Drug Interactions in the Critically Sick Elderly Patients in China

Potential drug interactions in patients admitted to cardiology wards of a south Indian teaching hospital

Frequency, Predictors, and Outcomes of the Potential Drug-Drug Interactions in the ICUs of Teaching Hospitals in Ardabil, Northwest of Iran During 2019-2020

Epidemiology of potential drug- drug interactions in hospitalized patients with type 2 diabetes mellitus in China: a retrospective study

Drug use survey to identify significant drug-drug interactions and assess clinical importance in the outpatient setting of a tertiary care hospital

Prevalence and clinical significance of potential drug-drug interactions among lung transplant patients

Prevalence and comparative analysis of potential drug-drug interactions among hospitalized patients at a tertiary care cardiac institute in Pakistan: Findings from a single centre

Prevalence and predictors of potential drug–drug interactions in patients of internal medicine wards of a tertiary care hospital in India

Prevalence of Potential Drug–drug Interactions in Outpatients of a General Hospital in China: a Retrospective Investigation

Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study

Assessment of Physician's Knowledge of Potential Drug-Drug Interactions: An Online Survey in China

Assessment of potential drug-drug interactions at hospital discharge

Clinical Pertinence and Determinants of Potential Drug-Drug Interactions in Chronic Kidney Disease Patients: A Cross-sectional Study

Pharmacist-driven Antimicrobial Stewardship in Intensive Care Units in East China: A Multicenter Prospective Cohort Study